mRNA Synthesis Reagents And Manufacturing: Research Through Clinical Development

Advances in messenger RNA (mRNA) technology have recently led to a wide range of potential uses for treating and preventing diseases. As novel mRNA therapies are starting to enter clinical stages of development, Aldevron is providing critical support in a number of ways with specialized products and services.

Aldevron manufactures the recombinant enzymes needed for mRNA synthesis by in vitro transcription, post-transcriptional capping, and post-transcriptional tailing. These are offered individually or in kits for research use and can be provided on a custom basis for use in cGMP manufacturing. Aldevron also provides pDNA template and mRNA manufacturing services using materials and processes that are scalable over the entire range of quality grades ensuring a seamless transition from research through clinical stages of development.